DNA-based immunization against the envelope proteins of the hepatitis B virus

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 47-57

  Mancini, Maryline ^a   Davis, Heather ^b   Tiollais, Pierre ^a   Michel, Marie Louise ^a  

^a INSTITUT PASTEUR   (France)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Genetic vaccine; Hepatitis B surface antigen (BsAg); Hepatitis B virus (HBV); Humoral response; Pre S1 antibody

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; DNA; LIVING SYSTEMS STUDIES; PROTEINS; VACCINES; VIRUSES;

ENVELOPE PROTEINS; GENETIC VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS; HUMORAL RESPONSE;

IMMUNIZATION;

HEPATITIS B VACCINE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HEPATITIS B VIRUS; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS ENVELOPE;

EID: 0030063276     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00098-4     Document Type: Conference Paper

References (38)

1. Alberti, A., Cavalletto, D., Pontisso, P., Chemello, L., Tagariello, G. and Belussi, F. (1988) Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 331, 1421-1424.
2. Andre, F.E. (1990) Overview of a 5-year clinical experience with a yeast derived hepatitis B vaccine. Vaccine 8, S74-S78.
3. Budkowska, A., Riottot, M.-M., Dubreuil, P., Lazizi, Y., Brechot, C., Sobczak, E., Petit, M.-A. and Pillot, J. (1986) Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus. J. Med. Virol. 20, 111-125.
4. Budkowska, A., Dubreuil, P., Poynard, T., Marcellin, P., Loriot, M.-A., Maillard, P. and Pillot, J. (1992) Anti-pre-S responses and viral clearance in chronic hepatitis B virus infection. Hepatology 15, 26-31.
5. Cabezon, T., Rutgers, T., Biemans, R., Vanderbrugge, D., Voet, P. and De Wilde, M. (1990) A new hepatitis B vaccine containing pre-S1 and pre-S2 epitopes from Saccharomyces cerevisiae. In: Brown, F., Chanock, R.M., Ginsberg, H.S. and Lerner, R.A. (Eds.), Vaccines 90. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 199-203.
6. Couroucé-Pauty, A.-M., Naret, C., Ciancionni, C., Adhemar, J.P. and Soulier, J.P. (1978) Prevention of viral hepatitis B in hemodialysis units by means of anti HBs immunoglobulins. In: Transplantation and Clinical Immunology. Excerpta Medica, Lyon, pp. 77-85.
7. Cox, G.J., Zamb, T.J. and Babiuk, L.A. (1993) Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664-5667.
8. Davis, H.L., Michel, M.-L. and Whalen, R.G. (1993a) DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum. Molec. Genet. 2, 1847-1851.
9. Davis, H.L., Whalen, R.G. and Demeneix, B.A. (1993b) Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
10. Davis, H.L., Michel, M.-L., Mancini, M., Schleef, M. and Whalen, R.G. (1994) Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine, 12 No. 16, 1503-1509.
11. Davis, H.L., Schirmbeck, R., Reimann, J., Whalen, R.G. (1995) DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum. Gene Ther., submitted.
12. Emini, E.A., Larson, V., Eichberg, J., Conard, P., Garsky, V.M., Lee, D.R., Ellis, R.W., Anderson, C.A. and Gerety, R.J. (1989) Protective effect of a synthetic peptide comprising the complete pre-S2 region of the hepatitis B virus surface protein. J. Med. Virol. 28, 7-11.
13. Ferrari, C., Penna, A., Bertoletti, A., Cavalli, A., Valli, A., Schianchi, C. and Riacciadori, F. (1989) The preS1 antigen of hepatitis B virus is highly immunogenetic at the T cell level in man. J. Clin. Invest. 84, 1314-1319.
14. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. (1993) DNA vaccines: Protective immunizations by parental, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482.
15. Gagliardi, M.-C., Nisini, R., Benvenuto, R., De Petrillo, G., Michel, M.-L. and Barnaba, V. (1994) Soluble transferrin mediates targeting of hepatitis B envelope antigen to transferrin receptor and its presentation by activated T cells. Eur. J. Immunol. 24, 1372-1376.
16. Hemmerling, A.E., Müller, R., Firusian, N., Grötz, J., Haubitz, M. and Thoma, H.A. (1994) Clinical experience with the pre-S1-containing hepatitis B vaccine (HG-3) in different nonresponder groups. In: Nishioka, K., Suzuki, H., Mishiro, S. and Oda, T. (Eds.), Viral Hepatitis and Liver Disease. Springer, Tokyo, pp. 540-542.
17. Itoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakawa, Y. and Mayumi, M. (1986) A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: Protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. USA 83, 9174-9178.
18. Kruskall, M.S., Alper, C.A., Awdeh, Z., Yunis, E.J. and Marcus-Bagley, D. (1992) The immune response to hepatitis B vaccine in humans: Inheritance patterns in families. J. Exp. Med. 175, 495-502.
19. Mancini, M., Hadchouel, M., Tiollais, P., Pourcel, C. and Michel, M.L. (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing 'non-response' to HBsAg. J. Med. Virol. 39, 67-74.
20. Michel, M.L., Pontisso, P., Sobczak, E., Malpièce, Y., Streeck, R.E. and Tiollais, P. (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc. Natl. Acad. Sci. USA 81, 7708-7712.
21. Michel, M.L., Mancini, M., Rivière, Y., Dormont, D., Tiollais, P. (1990) T- and B-lymphocyte responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/hepatitis B surface antigen particles. J. Virol. 64, 2452-2455.
22. Michel, M.L., Davis, H.L., Schleef, M., Mancini, M., Tiollais, P. and Whalen, R.G. (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. USA, 5307-5311.
23. Milich, D.R., Thornton, G.B., Neurath, A.R., Kent, S.B., Michel, M.L. and Tiollais, P. (1985) Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228, 1195-1199.
24. Milich, D.R., McLachlan, A., Chisari, F.V., Kent, S.B.H. and Thornton, G.B. (1986) Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass non-responsiveness to the pre-S(2) and S regions of HBsAg. J. Immunol. 137, 315-322.
25. Milman, G. and Herzberg, M. (1981) Efficient DNA transfection and rapid assay for thymidine kinase activity and viral antigenic determinants. Somatic Cell Genet. 7, 161-170.
26. Neurath, A.R., Kent, S.B.H., Strick, N., Taylor, P. and Stevens, C.E. (1985) Hepatitis B virus contains pre-S gene-encoded domains. Nature 315, 154-156.
27. Neurath, A.R., Kent, S.B.H., Parker, K., Prince, A.M., Strick, N., Brotman, B. and Sproul, P. (1986a) Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus-neutralizing. Vaccine 4, 35-37.
28. Neurath, A.R., Kent, S.B.H., Strick, N. and Parker, K. (1986b) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 426-436.
29. Neurath, A.R., Adamowicz, P., Kent, S.B.H., Riottot, M.-M., Strick, N., Parker, K., Offenperger, W., Petit, M.-A., Wahl, S., Budkowska, A., Girard, M. and Pillot, J. (1986c) Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. Mol. Immunol. 23, 991-997.
30. Neurath, A.R., Seto, B. and Strick, N. (1989) Antibodies to synthetic peptides from the pre-S1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7, 234-236.
31. Persing, D.H., Varmus, H.E. and Ganem, D. (1986) Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science 234, 1388-1389.
32. Prange, R., Clemen, A. and Streeck, R.E. (1991) Myristilation is involved in intracellular retention of hepatitis B virus envelope proteins. J. Virol. 65, 3919-3923.
33. Robinson, H.L., Hunt, L.A. and Webster, R.G. (1993) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957-60.
34. Tiollais, P., Pourcel, C. and Dejean, A. (1985) The hepatitis B virus. Nature 317, 489-495.
35. Tron, F., Degos, F., Bréchot, C., Couroucé, A.M., Goudeau, A., Marie, F.N., Adamowicz, P., Saliou, P., Laplanche, A., Benhamou, J.P. and Girard, M. (1989) Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and pre-S2 sequences. J. Infect. Dis. 160, 199-204.
36. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgner, P.L., Dwarki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L. and Liu, M.A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
37. Valenzuela, P., Medina, A., Rutter, W.J., Ammerer, G. and Hall, B.D. (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298, 347-350.
38. Xiang, Z.Q., Spitalnik, S., Tran, M. et al. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140.